Updated
The most significant concentration NVE discloses is Abbott Laboratories and other large customers, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: NVE’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1: 'We rely on several large customers for a significant percentage of our revenue, including Abbott Laboratories, certain distributors, and certain other customers.'”
“10-K Item 1: 'We have worldwide wafer sources; most of our packaging services take place in Asia.'”
NVE Corporation discloses two dependency-type concentration risks, both without specific percentage figures attached. On the customer side, the company relies on several large customers, including Abbott Laboratories, certain distributors, and certain other customers, for a significant percentage of its revenue — a reliance spread across a named set of large accounts rather than resting on a single dominant customer alone. On the supply side, NVE sources wafers worldwide but has most of its packaging services concentrated in Asia, an operational dependency on a specific geographic region for a key step in its manufacturing process. Neither exposure is quantified with a percentage in the filing, so their relative size cannot be directly compared, but both share the same character: reliance on a limited set of counterparties or locations rather than a structural feature spread evenly across the whole business. Netting these out, a disruption affecting Abbott Laboratories or the other named large customers would hit revenue directly, while a disruption to Asia-based packaging services would hit NVE's ability to deliver finished product regardless of demand — the two risks sit on opposite sides of the business (demand versus supply) and would need to be monitored independently rather than as a single combined exposure.
For the engine’s reasoning on NVEC’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ALAB | Astera Labs, Inc. | 3 | 0 | 0 | 3 |
| AMBQ | Ambiq Micro, Inc. | 2 | 1 | 0 | 3 |
| ADI | Analog Devices, Inc. | 2 | 0 | 0 | 2 |
| ALGM | Allegro MicroSystems, Inc. | 1 | 2 | 0 | 3 |
| NVEC● | NVE Corporation | 0 | 2 | 0 | 2 |
| AIP | Arteris, Inc. | 0 | 1 | 0 | 1 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.